Change history 03 August 2024 The e-mail addresses of both corresponding authors are swapped
define coverage, forecast demand, require prior auth & care plans, and insist on transparent PBM terms
It emphasizes that being otherwise healthy does not automatically make someone a good candidate, and calls for baseline metabolic labs, regular weight and symptom monitoring, and provider-led titration
Theres no official cut-off point, but several factors could lead someone to stop taking semaglutide injections
Participants who stayed on through 48 weeks saw A1C reductions averaging 2.02% in those with type 2 diabetes, triglyceride drops of 28%, systolic blood pressure decreases of 6.8 mmHg, and LDL cholesterol reductions of 12%
Decreased appetite and elimination of food chatter in head